Loading
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Latest filing published 10 Jun 2020 for STEMLINE THERAPEUTICS INC.
Insider track record
Disclosed buys
9
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
9
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Kenneth J. Zuerblis: trading record in brief
Filings by Kenneth J. Zuerblis span 3 companies, the busiest being Stemline Therapeutics Inc, Savient Pharmaceuticals Inc and Immunomedics Inc. Over a trading history stretching from 1 December 2010 to 10 June 2020, the count stands at 16 filings.
On the market, this insider has only ever bought: 9 purchases, €64k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 4 share grants and 2 option exercises.
Half of the purchases are above €7,345 and half below.
The record was last updated on 10 June 2020 with a transaction in Stemline Therapeutics Inc. The latest purchase dates back some time: it was published 4,432 days ago, on 4 September 2014. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kenneth J. Zuerblis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
60,121 sharesCommon StockSEC:0001104659-20-071825:0
15,000 shares0Common StockSEC:0001104659-19-038305:0
13,158 shares0Common StockSEC:0001104659-18-041872:0
10,000 shares0Common StockSEC:0001104659-17-040454:0
10,000 shares0Common StockSEC:0001104659-15-047708:0
1,000 shares@ US$11.14Common StockSEC:0001104659-14-064672:0
Canonical exit: 1 Dec 2014 (T+90)
600 shares@ US$15.85Common StockSEC:0001104659-13-046275:0
Canonical exit: 27 Aug 2013 (T+90)
500 shares@ US$15.86Common StockSEC:0001104659-13-046275:1
Canonical exit: 27 Aug 2013 (T+90)
1,000 shares@ US$15.86Common StockSEC:0001104659-13-046275:2
Canonical exit: 27 Aug 2013 (T+90)
200 shares@ US$16.38Common StockSEC:0001104659-13-046275:3
Canonical exit: 28 Aug 2013 (T+90)
700 shares@ US$16.38Common StockSEC:0001104659-13-046275:4
Canonical exit: 28 Aug 2013 (T+90)
5,000 sharesCommon StockSEC:0001209191-11-060555:0
2,000 shares@ US$2.35Common Stock, $.01 par value per shareSEC:0001181431-11-057052:0
Canonical exit: 16 Feb 2012 (T+90)
1,000 shares@ US$3.97Common Stock, $.01 par value per shareSEC:0001181431-11-049675:0
Canonical exit: 13 Dec 2011 (T+90)
4,000 shares@ US$4.05Common Stock, $.01 par value per shareSEC:0001181431-11-049675:1
Canonical exit: 14 Dec 2011 (T+90)
4,167 sharesCommon StockSEC:0001181431-10-059380:0
16 of 16 declarations
